Business

Arecor on Investor Meet Company Platform

Arecor on Investor Meet Company Platform.

articleArecor Therapeutics PlcSeptember 15, 20234/company/arecor-therapeutics-plc/news/arecor-on-investor-meet-company-platform
Arecor on Investor Meet Company Platform

About this update from Arecor Therapeutics Plc

[{"type":"text","content":"\n\nArecor Therapeutics plc\n(\"Arecor\" or the \"Group\")\n \nArecor to present on Investor Meet Company Platform\n \nCambridge, UK, 15 September 2023: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today's therapies to enable healthier lives, today announces that Sarah Howell, Chief Executive Officer and Susan Lowther, Chief Financial Officer will be providing a live presentation of the Group's recently announced results for the six months ended 30 June 2023 via the Investor Meet Company platform, on Wednesday 20 September at 2pm BST.\n \nThe presentation is open to all existing and potential shareholders and will be followed by a Q&A session. Questions can be submitted ahead of the event through the Investor Meet Company dashboard until 9am BST on Tuesday 19 September, or at any time during the live presentation.\n \nTo sign up to Investor Meet Company for free and to register for Arecor's presentation, please visit:\nhttps://www.investormeetcompany.com/arecor-therapeutics-plc/register-investor\n \nInvestors who already follow Arecor on the Investor Meet Company platform will automatically be invited to the event.\n \n \n-ENDS-\n \n \nFor more information, please contact:\n\n\n\nArecor Therapeutics plc\n\n\nwww.arecor.com\n\n\n\n\nDr Sarah Howell, Chief Executive Officer\n\n\nTel: +44 (0) 1223 426060\nEmail: [email protected]\n\n\n\n\n\n\n\n\n\n\n\n\nSusan Lowther, Chief Financial Officer\n\n\nTel: +44 (0) 1223 426060\nEmail: [email protected]\n\n\n\n\n \n\n\n\n\n\n\n\nMo Noonan, Communications\n\n\nTel: +44 (0) 7876 444977\nEmail: [email protected]\n\n\n\n\n\n\n\n\n\n\n\n\nPanmure Gordon (UK) Limited (NOMAD and Broker)\n\n\n\n\n\n\n\nFreddy Crossley, Emma Earl (Corporate Finance)\nRupert Dearden (Corporate Broking)\n\n\nTel: +44 (0) 20 7886 2500\n \n\n\n\n\n\n\n\n\n\n\n\n\nConsilium Strategic Communications\n\n\n\n\n\n\n\nChris Gardner, David Daley, Lindsey Neville\n\n\nTel: +44 (0) 20 3709 5700\nEmail: [email protected]\n\n\n\n\n \n\n\n\n\n\n\n \nNotes to Editors\n \nAbout Arecor\nArecor Therapeutics plc is a globally focused biopharmaceutical group transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary for...

More updates from Arecor Therapeutics Plc